Cargando…
Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia
BACKGROUND: Preferred anticonvulsant used to treat and prevent fits in eclampsia currently is magnesium sulphate. Clinical monitoring of tendon reflexes, respiration rate and measuring hourly urine output should be done to ensures safe administration of magnesium sulphate OBJECTIVE: This study was c...
Autores principales: | Kassie, Gizat M., Negussie, Dereje, Ahmed, Jemal H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100951/ https://www.ncbi.nlm.nih.gov/pubmed/25035717 |
Ejemplares similares
-
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Treatment of Eclampsia with Magnesium Sulphate
por: Quddus, M. A.
Publicado: (1946) -
Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021) -
Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia
por: De Silva, Dane A., et al.
Publicado: (2017) -
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
por: Long, Q, et al.
Publicado: (2016)